Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04409964Completed
Randomised trial of dexmedetomidine and Lidocaine Hydrochloride Injection, without epinephrine in gynecologic disease (2 arms), sponsored by The Catholic University of Korea. Primary endpoint: Quality of Recovery-40. Started Jun 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04409964.